Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury

Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445

Bats Are Natural Reservoirs of SARS-Like Coronaviruses

Li, W., Shi, Z., Yu, M., Ren, W., Smith, C. S., Epstein, J. H., Wang, H., Crameri, G. S., Hú, Z., Zhang, H., et al. (2005) · Science · doi:10.1126/science.1118391 · Cited by 2,571

Angiotensin-converting enzyme 2 protects from severe acute lung failure

Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., et al. (2005) · Nature · doi:10.1038/nature03712 · Cited by 2,453

Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor

Li, F., Li, W., Farzan, M., & Harrison, S. C. (2005) · Science · doi:10.1126/science.1116480 · Cited by 2,035

Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus

Weiss, S. R., & Navas-Martin, S. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.4.635-664.2005 · Cited by 1,256

Severe acute respiratory syndrome

Peiris, M. J. S., Guan, Y., & Yuen, K. (2004) · Nature Medicine · doi:10.1038/nm1143 · Cited by 1,157

Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV

Lambeir, A.-M., Durinx, C., Scharpé, S., & De Meester, I. (2003) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/713609354 · Cited by 955

Human aminopeptidase N is a receptor for human coronavirus 229E

Yeager, C. L., Ashmun, R. A., Williams, R. K., Cardellichio, C. B., Shapiro, L. H., Look, A. T., & Holmes, K. V. (1992) · Nature · doi:10.1038/357420a0 · Cited by 941

The Antiviral Potential of Host Protease Inhibitors

Steinmetzer, T., & Hardes, K. (2018) · Springer eBooks · doi:10.1007/978-3-319-75474-1_11 · Cited by 26

Coronavirus disease 2019—Historical context, virology, pathogenesis, immunotherapy, and vaccine development

Ezzikouri, S., Nourlil, J., Benjelloun, S., Kohara, M., & Tsukiyama–Kohara, K. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1787068 · Cited by 26

COVID-19 and diabetes; Possible role of polymorphism and rise of telemedicine

Sayed, S. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.08.018 · Cited by 26

Host Receptors of Influenza Viruses and Coronaviruses—Molecular Mechanisms of Recognition

Sriwilaijaroen, N., & Suzuki, Y. (2020) · Vaccines · doi:10.3390/vaccines8040587 · Cited by 26

Coronavirus Disease 2019 (COVID-19): Current Situation and Therapeutic Options

Singh, V., & Mishra, V. (2020) · Coronaviruses · doi:10.2174/2666796701999201005211854 · Cited by 26

Attenuation of SARS-CoV-2 infection by losartan in human kidney organoids

Rahmani, W., Chung, H., Sinha, S., Bui-Marinos, M. P., Arora, R., Jaffer, A., Corcoran, J. A., Biernaskie, J., & Chun, J. (2022) · iScience · doi:10.1016/j.isci.2022.103818 · Cited by 25

Neutralizing Monoclonal Antibodies as Promising Therapeutics against Middle East Respiratory Syndrome Coronavirus Infection

Han, H.-J., Liu, J.-W., Yu, H., & Yu, X. (2018) · Viruses · doi:10.3390/v10120680 · Cited by 25

Kidney manifestations of mild, moderate and severe coronavirus disease 2019: a retrospective cohort study

Hong, D., Lin, L., Wang, Y., Yu, L., Tang, Y., Zhao, J. W., Song, X., He, Y., Wen, E., Zheng, L., et al. (2020) · Clinical Kidney Journal · doi:10.1093/ckj/sfaa083 · Cited by 25

Druggable targets from coronaviruses for designing new antiviral drugs

Silva, L. R., Santos-Júnior, P. F. D. S., Brandão, J. D. A., Anderson, L., Bassi, Ê. J., de Araújo‐Júnior, J. X., Cardoso, S. H., & da Silva‐Júnior, E. F. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115745 · Cited by 25

Can Coronaviruses Steal Genes from the Host as Evidenced in Western European Hedgehogs by EriCoV Genetic Characterization?

Sabato, L. D., Bartolo, I. D., Marco, M. A. D., Moreno, A. M., Lelli, D., Cotti, C., Delogu, M., & Vaccari, G. (2020) · Viruses · doi:10.3390/v12121471 · Cited by 25

The Potential Therapeutic Effect of RNA Interference and Natural Products on COVID-19: A Review of the Coronaviruses Infection

Kalhori, M. R., Saadatpour, F., Arefian, E., Soleimani, M., Farzaei, M. H., Aneva, I. Y., & Echeverría, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.616993 · Cited by 25

MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein

Park, B. K., Kim, J., Park, S., Kim, D., Kim, M., Baek, K., Bae, J., Park, M., Kim, W., Lee, Y., et al. (2021) · Theranostics · doi:10.7150/thno.55647 · Cited by 25

COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery

Kumar, S., Basu, M., Ghosh, P., Pal, U., & Ghosh, M. K. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.12.019 · Cited by 25

Evolving sequence mutations in the Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

Balwi, M. A. A., Khan, A., Aldrees, M., Gk, U. R., Manie, B., Arabi, Y. M., Alabdulkareem, I. B., AlJohani, S. M., Alghoribi, M. F., Alaskar, A. S., et al. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.06.030 · Cited by 25

Interaction of Severe Acute Respiratory Syndrome Coronavirus 2 and Diabetes

Shao, S., Yang, Q., Pan, R., Yu, X., & Chen, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.731974 · Cited by 27

Middle East respiratory syndrome coronavirus (MERS-CoV): Impact on Saudi Arabia, 2015

Faridi, U. A. (2016) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2016.09.020 · Cited by 24

Suggested new breakpoints of anti-MERS-CoV antibody ELISA titers: performance analysis of serologic tests

Ko, J., Müller, M. A., Seok, H., Park, G., Lee, J., Cho, S. Y., Ha, Y. E., Baek, J. Y., Kim, S.-H., Kang, J., et al. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3043-3 · Cited by 24

Interactions between antihyperglycemic drugs and the renin-angiotensin system: Putative roles in COVID-19. A mini-review

Nakhleh, A., & Shehadeh, N. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.040 · Cited by 24

Acute kidney injury in COVID-19; a review on current knowledge

Aleebrahim‐Dehkordi, E., Reyhanian, A., Saberianpour, S., & Dehkordi, A. H. (2020) · Journal of Nephropathology · doi:10.34172/jnp.2020.31 · Cited by 24

Beyond the lung involvement in COVID-19 patients

Tuttolomondo, D., Frizzelli, A., Aiello, M., Bertorelli, G., Majori, M., & Chetta, A. A. (2021) · Minerva Medica · doi:10.23736/s0026-4806.20.06719-1 · Cited by 24

Double-Barreled CRISPR Technology as a Novel Treatment Strategy For COVID-19

Nalawansha, D. A., & Samarasinghe, K. T. G. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00071 · Cited by 24

SARS-CoV-2: An Overview of Virus Genetics, Transmission, and Immunopathogenesis

Farrag, M. A., Amer, H. M., Bhat, R., Hamed, M. E., Aziz, I. M., Mubarak, A., Dawoud, T. M. S., Almalki, S. G., Alghofaili, F., Alnemare, A. K., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18126312 · Cited by 28

Glucose-lowering drugs and outcome from COVID-19 among patients with type 2 diabetes mellitus: a population-wide analysis in Hong Kong

Luk, A. O. Y., Yip, T. C., Zhang, X., Kong, A. P. S., Wong, V. W., Ronald, C. W., & Wong, G. L. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-052310 · Cited by 24

COVID-19 and Diabetes Outcomes: Rationale for and Updates from the CORONADO Study

Smati, S., Tramunt, B., Wargny, M., Gourdy, P., Hadjadj, S., & Cariou, B. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01452-5 · Cited by 27

Plant Molecular Pharming and Plant-Derived Compounds towards Generation of Vaccines and Therapeutics against Coronaviruses

Venkataraman, S. (2022) · Vaccines · doi:10.3390/vaccines10111805 · Cited by 24

Development of animal models for emerging infectious diseases by breaking the barrier of species susceptibility to human pathogens

Rong, N., & Liu, J. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2178242 · Cited by 27

Diabetes as one of the long-term COVID-19 complications: from the potential reason of more diabetic patients’ susceptibility to COVID-19 to the possible caution of future global diabetes tsunami

Sharbatdar, Y., Mousaviyan, R., Varnosfaderani, S. M. N., Aziziyan, F., Liaghat, M., Baziyar, P., Rad, A. Y., Tavakol, C., Moeini, A. M., Nabi‐Afjadi, M., et al. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01215-y · Cited by 24

Unraveling DPP4 Receptor Interactions with SARS-CoV-2 Variants and MERS-CoV: Insights into Pulmonary Disorders via Immunoinformatics and Molecular Dynamics

Roy, A. N., Gupta, A. M., Banerjee, D., Chakrabarti, J., & Raghavendra, P. B. (2023) · Viruses · doi:10.3390/v15102056 · Cited by 24

The Amino Acids 736–761 of the MERS-CoV Spike Protein Induce Neutralizing Antibodies: Implications for the Development of Vaccines and Antiviral Agents

Yang, Y., Deng, Y. L., Wen, B., Wang, H., Meng, X., Lan, J., Gao, G. F., & Tan, W. (2014) · Viral Immunology · doi:10.1089/vim.2014.0080 · Cited by 24

Putative Receptor Binding Domain of Bat-Derived Coronavirus HKU9 Spike Protein: Evolution of Betacoronavirus Receptor Binding Motifs

Huang, C., Qi, J., Lu, G., Wang, Q., Yuan, Y., Wu, Y., Zhang, Y., Yan, J., & Gao, G. F. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00790 · Cited by 24

Biology of Viruses and Viral Diseases

Chappell, J. D., & Dermody, T. S. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00134-x · Cited by 24

Combining a Fusion Inhibitory Peptide Targeting the MERS-CoV S2 Protein HR1 Domain and a Neutralizing Antibody Specific for the S1 Protein Receptor-Binding Domain (RBD) Showed Potent Synergism against Pseudotyped MERS-CoV with or without Mutations in RBD

Wang, C., Hua, C., Xia, S., Li, W., Lu, L., & Jiang, S. (2019) · Viruses · doi:10.3390/v11010031 · Cited by 24

Middle East Respiratory Syndrome Coronavirus Antibodies in Bactrian and Hybrid Camels from Dubai

Lau, S. K. P., Li, K. S. M., Luk, H. K. H., He, Z., Teng, J. L. L., Yuen, K., Wernery, U., & Woo, P. C. Y. (2020) · mSphere · doi:10.1128/msphere.00898-19 · Cited by 24

Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight

He, C., Qin, M., & Sun, X. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.05.009 · Cited by 24

Discovery and characterization of ACE2 – a 20-year journey of surprises from vasopeptidase to COVID-19

Hooper, N. M., Lambert, D., & Turner, A. J. (2020) · Clinical Science · doi:10.1042/cs20200476 · Cited by 24

Interrelationship between 2019-nCov receptor DPP4 and diabetes mellitus targets based on protein interaction network

Gao, Q., Zhang, W., Li, T., Yang, G., Zhu, W., Chen, N., & Jin, H. (2022) · Scientific Reports · doi:10.1038/s41598-021-03912-6 · Cited by 24

Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC

Du, L., Ma, C., & Jiang, S. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.05.002 · Cited by 24

Phytocompounds of Rheum emodi, Thymus serpyllum and Artemisia annua inhibit COVID-19 binding to ACE2 receptor: In silico approachPreprint

Rolta, R., Salaria, D., Kumar, V., Sourirajan, A., & Dev, K. (2020) · doi:10.21203/rs.3.rs-30938/v1 · Cited by 24

Caring for hospitalized patients with diabetes mellitus, hyperglycemia, and COVID-19: bridging the remaining knowledge gaps

Wallia, A., Prince, G., Touma, E., El Muayed, M., & Seley, J. J. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01366-0 · Cited by 23

Molecular aspects of MERS-CoV

Rabaan, A. A., Bazzi, A. M., Al-Ahmed, S. H., & Al‐Tawfiq, J. A. (2017) · Frontiers of Medicine · doi:10.1007/s11684-017-0521-z · Cited by 23

Three Main Inducers of Alphacoronavirus Infection of Enterocytes: Sialic Acid, Proteases, and Low pH

Yuan, P., Yang, Z., Song, H. S., Wang, K., Yang, Y., Xie, L., Huang, S., Liu, J., Ran, L., & Song, Z. (2018) · Intervirology · doi:10.1159/000492424 · Cited by 23

The broad-spectrum antiviral recommendations for drug discovery against COVID-19

Hazafa, A., ur-Rahman, K., Haq, I. U., Jahan, N., Mumtaz, M., Farman, M. T., Naeem, H., Abbas, F., Naeem, M., Sadiqa, S., et al. (2020) · Drug Metabolism Reviews · doi:10.1080/03602532.2020.1770782 · Cited by 23

An Overview of the Pathogenesis, Transmission, Diagnosis, and Management of Endemic Human Coronaviruses: A Reflection on the Past and Present Episodes and Possible Future Outbreaks

Kayode, A. J., Banji-Onisile, F. O., Olaniran, A. O., & Okoh, A. I. (2021) · Pathogens · doi:10.3390/pathogens10091108 · Cited by 23

Identification of potential therapeutic targets and mechanisms of COVID-19 through network analysis and screening of chemicals and herbal ingredients

Wang, H., Zhang, J., Lu, Z., Dai, W., Ma, C., Xiang, Y., & Zhang, Y. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab373 · Cited by 23

Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors

Weidenbacher, P. A. B., Waltari, E., Kobara, I. D. L. R., Bell, B. N., Morris, M. K., Cheng, Y.-C., Hanson, C. V., Pak, J. E., & Kim, P. S. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01140-1 · Cited by 23

Nuclear translocation of spike mRNA and protein is a novel feature of SARS-CoV-2

Sattar, S., Kabát, J., Jerome, K., Feldmann, F., Bailey, K. L., & Mehedi, M. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1073789 · Cited by 23

Antiviral activity of marine sulfated glycans against pathogenic human coronaviruses

Zoepfl, M., Dwivedi, R., Kim, S. B., McVoy, M. A., & Pomin, V. H. (2023) · Scientific Reports · doi:10.1038/s41598-023-31722-5 · Cited by 23

Mosaic RBD Nanoparticles Elicit Protective Immunity Against Multiple Human Coronaviruses in Animal Models

Zhang, Y., Sun, J., Zheng, J. H., Li, S., Rao, H., Dai, J., Zhang, Z., Wang, Y., Liu, D., Chen, Z., et al. (2023) · Advanced Science · doi:10.1002/advs.202303366 · Cited by 24

Hunting Viral Receptors Using Haploid Cells

Pillay, S., & Carette, J. E. (2015) · Annual Review of Virology · doi:10.1146/annurev-virology-100114-055119 · Cited by 23

Applications of Replicating-Competent Reporter-Expressing Viruses in Diagnostic and Molecular Virology

Li, Y., Li, L., Yu, S., Wang, X., Zhang, L., Yu, J., Xie, L., Li, W., Ali, R., & Qiu, H. (2016) · Viruses · doi:10.3390/v8050127 · Cited by 23

The COVID-19 pandemic – How many times were we warned before?

Mahroum, N., Seida, I., Esirgün, S. N., & Bragazzi, N. L. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.07.009 · Cited by 23

Close relatives of MERS-CoV in bats use ACE2 as their functional receptorsPreprint

Xiong, Q., Cao, L., Ma, C., Liu, C., Si, J., Liu, P., Gu, M., Wang, C., Shi, L., Tong, F., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.24.477490 · Cited by 23

Toward Developing a Preventive MERS-CoV Vaccine—Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14–15, 2015

Excler, J., Delvecchio, C. J., Wiley, R. E., Williams, M., Yoon, I., Modjarrad, K., Boujelal, M., Moorthy, V., Hersi, A. S., Kim, J. H., et al. (2016) · Emerging infectious diseases · doi:10.3201/eid2208.160229 · Cited by 22

Middle East respiratory syndrome coronavirus: current knowledge and future considerations

Malik, M. R., Elkholy, A. A., Khan, W., Hassounah, S., Abubakar, A., Minh, N. N. T., & Mala, P. O. (2016) · Eastern Mediterranean Health Journal · doi:10.26719/2016.22.7.533 · Cited by 22

Molecular Basis of Binding between Middle East Respiratory Syndrome Coronavirus and CD26 from Seven Bat Species

Yuan, Y., Qi, J., Peng, R., Li, C., Lu, G., Yan, J., Wang, Q., & Gao, G. F. (2019) · Journal of Virology · doi:10.1128/jvi.01387-19 · Cited by 22

Combination of Biodata Mining and Computational Modelling in Identification and Characterization of ORF1ab Polyprotein of SARS-CoV-2 Isolated from Oronasopharynx of an Iranian Patient

Emameh, R. Z., Nosrati, H., & Taheri, R. A. (2020) · Biological Procedures Online · doi:10.1186/s12575-020-00121-9 · Cited by 22

COVID-19 and diabetes mellitus: implications for prognosis and clinical management

Barber, T. M. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1774360 · Cited by 22

Antimalarials as Antivirals for COVID-19: Believe it or Not!

Saha, B. K., Bonnier, A., & Chong, W. H. (2020) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2020.08.019 · Cited by 22

Crosstalk Between Coronavirus Disease 2019 and Cardiovascular Disease and Its Treatment

Ye, Q., Lu, D., Shang, S., Fu, J., Gong, F., Shu, Q., & Mao, J. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12960 · Cited by 24

The use of mesenchymal stromal cells in the treatment of coronavirus disease 2019

Canham, M. A., Campbell, J. D. M., & Mountford, J. C. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02532-4 · Cited by 22

Therapy of Type 2 Diabetes in Patients with SARS-CoV-2 Infection

Bielka, W., Przezak, A., & Pawlik, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147605 · Cited by 23

A Review on Expression, Pathological Roles, and Inhibition of TMPRSS2, the Serine Protease Responsible for SARS-CoV-2 Spike Protein Activation

Sarker, J., Das, P., Sarker, S., Roy, A. K., & Momen, A. Z. M. R. (2021) · Scientifica · doi:10.1155/2021/2706789 · Cited by 23

Receptor-binding domain of SARS-CoV-2 spike protein efficiently inhibits SARS-CoV-2 infection and attachment to mouse lung

Shin, H. J., Ku, K. B., Kim, H. S., Moon, H.-W., Jeong, G. U., Hwang, I., Yoon, G. Y., Lee, S.-H., Lee, S., Ahn, D., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.61320 · Cited by 22

A Randomized Clinical Trial of Linagliptin vs. Standard of Care in Patients Hospitalized With Diabetes and COVID-19

Abuhasira, R., Ayalon‐Dangur, I., Zaslavsky, N., Koren, R., Keller, M., Dicker, D., & Grossman, A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.794382 · Cited by 23

Comprehensive Oncogenic Features of Coronavirus Receptors in Glioblastoma Multiforme

Chen, A., Zhao, W., Li, X., Sun, G., Ma, Z., Peng, L., Shi, Z., Li, X., & Yan, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.840785 · Cited by 23

DPP-4 Inhibitors as a Savior for COVID-19 Patients with Diabetes

Nag, S., Mandal, S., Mukherjee, O., Mukherjee, S., & Kundu, R. (2023) · Future Virology · doi:10.2217/fvl-2022-0112 · Cited by 22

2-thiouridine is a broad-spectrum antiviral nucleoside analogue against positive-strand RNA viruses

Uemura, K., Nobori, H., Sato, A., Toba, S., Kusakabe, S., Sasaki, M., Tabata, K., Matsuno, K., Maeda, N., Ito, S., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2304139120 · Cited by 23

Other Viral Pneumonias

Lee, N. L. S., & Qureshi, S. T. (2013) · Critical Care Clinics · doi:10.1016/j.ccc.2013.07.003 · Cited by 22

Cardiovascular safety of dipeptidyl peptidase-4 inhibitors: recent evidence on heart failure.

Kankanala, S., Syed, R. M., Gong, Q., Ren, B., Rao, X., & Zhong, J. (2016) · PubMed Central · Cited by 22

Co‐localization of Middle East respiratory syndrome coronavirus ( MERS ‐CoV) and dipeptidyl peptidase‐4 in the respiratory tract and lymphoid tissues of pigs and llamas

Te, N., Vergara‐Alert, J., Lehmbecker, A., Pérez, M., Haagmans, B. L., Baumgärtner, W., Bensaïd, A., & Segalés, J. (2018) · Transboundary and Emerging Diseases · doi:10.1111/tbed.13092 · Cited by 22

Coronavirus Receptors as Immune Modulators

Devarakonda, C. K. V., Meredith, E. K., Ghosh, M., & Shapiro, L. H. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2001062 · Cited by 22

A stable platform for the production of virus-like particles pseudotyped with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein

Roy, S., Ghani, K., de Campos-Lima, P. O., & Caruso, M. (2021) · Virus Research · doi:10.1016/j.virusres.2021.198305 · Cited by 23

Chimeric Porcine Deltacoronaviruses with Sparrow Coronavirus Spike Protein or the Receptor-Binding Domain Infect Pigs but Lose Virulence and Intestinal Tropism

Niu, X., Hou, Y. J., Jung, K., Kong, F., Saif, L. J., & Wang, Q. (2021) · Viruses · doi:10.3390/v13010122 · Cited by 22

Coronaviruses Associated with the Superfamily Musteloidea

Stout, A. E., Guo, Q., Millet, J. K., de Matos, R., & Whittaker, G. R. (2021) · mBio · doi:10.1128/mbio.02873-20 · Cited by 22

Chemokine Regulation During Epidemic Coronavirus Infection

Majumdar, S., & Murphy, P. M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.600369 · Cited by 22

Can cilia provide an entry gateway for SARS-CoV-2 to human ciliated cells?

Buqaileh, R., Saternos, H. C., Ley, S. T., Aranda, A., Forero, K. V., & AbouAlaiwi, W. A. (2021) · Physiological Genomics · doi:10.1152/physiolgenomics.00015.2021 · Cited by 22

Influenza Virus and SARS-CoV-2 Vaccines

Sandor, A., Sturdivant, M. S., & Ting, J. P. ‐. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001287 · Cited by 23

Immunotherapeutic Efficacy of IgY Antibodies Targeting the Full-Length Spike Protein in an Animal Model of Middle East Respiratory Syndrome Coronavirus Infection

El-Kafrawy, S. A., Abbas, A. T., Sohrab, S. S., Tabll, A. A., Hassan, A. M., Iwata‐Yoshikawa, N., Nagata, N., & Azhar, E. I. (2021) · Pharmaceuticals · doi:10.3390/ph14060511 · Cited by 22

ACE2 interaction with cytoplasmic PDZ protein enhances SARS-CoV-2 invasion

Zhang, Q., Gefter, J. V., Sneddon, W. B., Mamonova, T., & Friedman, P. A. (2021) · iScience · doi:10.1016/j.isci.2021.102770 · Cited by 22

The Role of Post-Translational Modifications of Chemokines by CD26 in Cancer

Zutter, A. D., Damme, J. V., & Struyf, S. (2021) · Cancers · doi:10.3390/cancers13174247 · Cited by 22

Coronaviruses fusion with the membrane and entry to the host cell

Wędrowska, E., Wandtke, T., Senderek, T., Piskorska, E., & Kopiński, P. (2020) · Annals of Agricultural and Environmental Medicine · doi:10.26444/aaem/122079 · Cited by 21

The Potential Role of Renin Angiotensin System (RAS) and Dipeptidyl Peptidase-4 (DPP-4) in COVID-19: Navigating the Uncharted

Al-Kuraishy, H. M., Al‐Niemi, M. S., Hussain, N. R., Al-Gareeb, A. I., Al‐Harchan, N. A., & Al-Kurashi, A. H. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.92837 · Cited by 21

The COVID-19 pandemic: biological evolution, treatment options and consequences

Das, S., Das, S., & Ghangrekar, M. M. (2020) · Innovative Infrastructure Solutions · doi:10.1007/s41062-020-00325-8 · Cited by 21

TWIRLS , a knowledge‐mining technology, suggests a possible mechanism for the pathological changes in the human host after coronavirus infection via ACE2

Ji, X., Tan, W., Zhang, C., Zhai, Y., Hsueh, Y.-C., Zhang, Z., Zhang, C., Lu, Y., Duan, B., Tan, G., et al. (2020) · Drug Development Research · doi:10.1002/ddr.21717 · Cited by 21

Current Understanding of Novel Coronavirus: Molecular Pathogenesis, Diagnosis, and Treatment Approaches

Jha, N. K., Jeyaraman, M., Rachamalla, M., Ojha, S. K., Dua, K., Chellappan, D. K., Muthu, S., Sharma, A., Jha, S. K., Jain, R., et al. (2021) · Immuno · doi:10.3390/immuno1010004 · Cited by 21

Management of Patients With Glucocorticoid-Related Diseases and COVID-19

Chifu, I. O., Detomas, M., Dischinger, U., Kimpel, O., Megerle, F., Hahner, S., Faßnacht, M., & Altieri, B. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.705214 · Cited by 21

Toxoplasma gondii SAG1 targeting host cell S100A6 for parasite invasion and host immunity

Zhou, L.-J., Peng, J., Chen, M., Yao, L.-J., Zou, W., He, C. Y., & Peng, H. (2021) · iScience · doi:10.1016/j.isci.2021.103514 · Cited by 21

Risk Factors for COVID-19: Diabetes, Hypertension, and Obesity

Buscemi, S., Corleo, D., & Randazzo, C. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-85113-2_7 · Cited by 24

COVID-19 and diabetes—Two giants colliding: From pathophysiology to management

Pelle, M. C., Zaffina, I., Provenzano, M., Moirano, G., & Arturi, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.974540 · Cited by 22

Identification and Genetic Characterization of MERS-Related Coronavirus Isolated from Nathusius’ Pipistrelle (Pipistrellus nathusii) near Zvenigorod (Moscow Region, Russia)

Speranskaya, A. S., Artyushin, I. V., Samoilov, A. E., Korneenko, E. V., Khabudaev, K. V., Ilina, E. N., Yuzefovich, A. P., Safonova, M. V., Dolgova, A. S., Gladkikh, A. S., et al. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20043702 · Cited by 21

MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection

Tai, W., Zheng, J. H., Zhang, X., Shi, J., Wang, G., Guan, X., Zhu, J., Perlman, S. M., & Du, L. (2023) · Virus Research · doi:10.1016/j.virusres.2023.199156 · Cited by 21

An update on Middle East respiratory syndrome: 2 years later

Al‐Tawfiq, J. A., & Memish, Z. A. (2015) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2015.1027689 · Cited by 21

The receptor binding domain of MERS-CoV: The dawn of vaccine and treatment development

Zhou, N., Zhang, Y., Zhang, J.-C., Feng, L., & Bao, J. (2013) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2013.11.006 · Cited by 21

Possible mechanisms of direct cardiovascular impact of GLP-1 agonists and DPP4 inhibitors

Bistola, V., Lambadiari, V., Dimitriadis, G., Ioannidis, I., Makrilakis, K., Tentolouris, N., Τσάπας, Α., & Parissis, J. (2018) · Heart Failure Reviews · doi:10.1007/s10741-018-9674-3 · Cited by 21

Heightened ACE Activity and Unfavorable Consequences in COVID-19 Diabetic Subjects

Sandooja, R., Vura, N. V. R. K., & Morocco, M. (2020) · International Journal of Endocrinology · doi:10.1155/2020/7847526 · Cited by 21

SARS-CoV-2 infection in patients with diabetes mellitus and hypertension: a systematic review

Deravi, N., Fathi, M., Vakili, K. G., Yaghoobpoor, S., Pirzadeh, M., Mokhtari, M., Fazel, T., Ahsan, E., & Ghaffari, S. (2020) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm.2020.03.78 · Cited by 21

The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play

Souza, P. F. N., Mesquita, F. P., Amaral, J. L., Landim, P. G. C., Lima, K. R. P., Costa, M. B., Farias, I. R., Lima, L. B., & Montenegro, R. C. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.02.203 · Cited by 21

A Comparison of the Clinical, Viral, Pathologic, and Immunologic Features of Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Coronavirus 2019 (COVID-19) Diseases

Barth, R. F., Buja, L. M., Barth, A. L., Carpenter, D. E., & Parwani, A. V. (2021) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2020-0820-sa · Cited by 23

Mass spectrometry-based proteomics in basic and translational research of SARS-CoV-2 coronavirus and its emerging mutants

Rais, Y., Fu, Z., & Drabovich, A. P. (2021) · Clinical Proteomics · doi:10.1186/s12014-021-09325-x · Cited by 23

Counter-regulatory renin-angiotensin system in hypertension: review and update in the era of COVID-19 pandemic

Chen, H., Peng, J., Wang, T., Wen, J., Chen, S., Huang, Y., & Zhang, Y. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115370 · Cited by 19

Broad reception for coronavirus

Gallagher, T., & Perlman, S. M. (2013) · Nature · doi:10.1038/495176a · Cited by 32

Human Coronavirus EMC Is Not the Same as Severe Acute Respiratory Syndrome Coronavirus

Perlman, S. M., & Zhao, J. (2013) · mBio · doi:10.1128/mbio.00002-13 · Cited by 22

Human Coronavirus EMC Does Not Require the SARS-Coronavirus Receptor and Maintains Broad Replicative Capability in Mammalian Cell Lines

Müller, M. A., Raj, V. S., Muth, D., Meyer, B., Kallies, S., Smits, S. L., Wollny, R., Bestebroer, T. M., Specht, S., Suliman, T., et al. (2012) · mBio · doi:10.1128/mbio.00515-12 · Cited by 209

Putative conformations of the receptor-binding domain in S protein of hCoV-EMC in complex with its receptor dipeptidyl peptidase-4

Jiang, S., Lu, L., Du, L., & Debnath, A. K. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.04.007 · Cited by 12

The Emergence of Human Coronavirus EMC: How Scared Should We Be?

Chan, R. W. Y., & Poon, L. L. M. (2013) · mBio · doi:10.1128/mbio.00191-13 · Cited by 11